These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 38700303)
1. Glycemic Control and Mucormycosis during COVID-19 Pandemic in India a Study of Stage and Outcome. Sharma V; Kriplani K; Tuli IP; Sharma S; Narula A J Assoc Physicians India; 2023 Sep; 71(9):61-66. PubMed ID: 38700303 [TBL] [Abstract][Full Text] [Related]
2. Long-term Outcome of Coronavirus Disease-associated Mucormycosis: 1-year Follow-up Study from India. Agrawal P; Singh AP; Chakotiya PS; Kumar V; Gautam A; Kumar D J Assoc Physicians India; 2024 Jun; 72(6):44-48. PubMed ID: 38881134 [TBL] [Abstract][Full Text] [Related]
3. Diabetes, COVID 19 and mucormycosis: Clinical spectrum and outcome in a tertiary care medical center in Western India. Mishra Y; Prashar M; Sharma D; Akash ; Kumar VP; Tilak TVSVGK Diabetes Metab Syndr; 2021; 15(4):102196. PubMed ID: 34246939 [TBL] [Abstract][Full Text] [Related]
4. Cross-sectional study to describe the severity, bio-chemical associations, and final outcomes of COVID-19-associated rhino-orbital-cerebral mucormycosis in a tertiary hospital of East India. Kumari A; Ranjan A; Nishant P; Sinha S; Sinha RK Indian J Ophthalmol; 2023 May; 71(5):2193-2198. PubMed ID: 37202947 [TBL] [Abstract][Full Text] [Related]
5. Coronavirus disease-associated mucormycosis (CAM): A case control study during the outbreak in India. Wasiq M; K R; Gn A J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443518 [TBL] [Abstract][Full Text] [Related]
6. Association of Serum Iron Studies in COVID Associated Mucormycosis with Stage of the Disease. Rao C; R M J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443509 [TBL] [Abstract][Full Text] [Related]
7. Clinical Profile of Mucormycosis Patients during Coronavirus Disease 2019 Pandemic: A Retrospective Observational Study. Gondane B; Jain SK; Dube S J Assoc Physicians India; 2024 Mar; 72(3):27-31. PubMed ID: 38736113 [TBL] [Abstract][Full Text] [Related]
8. A fungal epidemic amidst a viral pandemic: Risk factors for development of COVID-19 associated rhino-orbital-cerebral mucormycosis in India. Vasanthapuram VH; Gupta R; Adulkar N; Nair AG; Bradoo RA; Hegde R; Singh U; Tadepalli S; Mukherjee B; Kamal S; Alam MS; Rao R; Ananthakrishna S; Backiavathy V; Murthy AK; D'Cunha L; Dudeja G; Joji A; Kiran A; Koka K; Goswami Mukhopadhyay M; Nisar SP; Rao PR; Shinde CA Orbit; 2023 Feb; 42(1):30-41. PubMed ID: 35192435 [TBL] [Abstract][Full Text] [Related]
9. Uncontrolled diabetes mellitus exacerbated by COVID-19-induced inflammation is the risk factor for COVID-19-associated rhino-orbito-cerebral mucormycosis: A matched pair case-control study. Karat S; Lobo AC; Satish D; Devaraj R; Manjooran RR; Nithyanandam S Indian J Ophthalmol; 2022 Aug; 70(8):3096-3101. PubMed ID: 35918980 [TBL] [Abstract][Full Text] [Related]
10. Mucormycosis and Covid-19 : Risk Factors, Clinical Presentation and Outcome in a Tertiary Care Centre in North India. A GA; Ashraf H; HaiderMehdi HS J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443512 [TBL] [Abstract][Full Text] [Related]
11. Preserved seasonal variation in glycemic control in patients with type 2 diabetes mellitus during COVID-19: a 3-year-long retrospective cohort study in older adults in Japan. Iwata S; Ashida K; Demiya M; Nagayama A; Hasuzawa N; Yoshinobu S; Sonezaki A; Yasuda J; Motomura S; Katsuki Y; Sugi K; Nomura M BMC Endocr Disord; 2024 May; 24(1):70. PubMed ID: 38755559 [TBL] [Abstract][Full Text] [Related]
12. Year-Long Trend in Glycated Hemoglobin Levels in Patients with Type 2 Diabetes during the COVID-19 Pandemic. Jin J; Lee SW; Lee WK; Jeon JH; Kim JG; Lee IK; Choi YK; Park KG Endocrinol Metab (Seoul); 2021 Oct; 36(5):1142-1146. PubMed ID: 34674507 [TBL] [Abstract][Full Text] [Related]
13. COVID associated mucormycosis: A preliminary study from a dedicated COVID Hospital in Delhi. Meher R; Wadhwa V; Kumar V; Shisha Phanbuh D; Sharma R; Singh I; Rathore PK; Goel R; Arora R; Garg S; Kumar S; Kumar J; Agarwal M; Singh M; Khurana N; Sagar T; Manchanda V; Saxena S Am J Otolaryngol; 2022; 43(1):103220. PubMed ID: 34547717 [TBL] [Abstract][Full Text] [Related]
14. Epidemiology, clinical profile, management, and outcome of COVID-19-associated rhino-orbital-cerebral mucormycosis in 2826 patients in India - Collaborative OPAI-IJO Study on Mucormycosis in COVID-19 (COSMIC), Report 1. Sen M; Honavar SG; Bansal R; Sengupta S; Rao R; Kim U; Sharma M; Sachdev M; Grover AK; Surve A; Budharapu A; Ramadhin AK; Tripathi AK; Gupta A; Bhargava A; Sahu A; Khairnar A; Kochar A; Madhavani A; Shrivastava AK; Desai AK; Paul A; Ayyar A; Bhatnagar A; Singhal A; Nikose AS; Bhargava A; Tenagi AL; Kamble A; Nariani A; Patel B; Kashyap B; Dhawan B; Vohra B; Mandke C; Thrishulamurthy C; Sambare C; Sarkar D; Mankad DS; Maheshwari D; Lalwani D; Kanani D; Patel D; Manjandavida FP; Godhani F; Agarwal GA; Ravulaparthi G; Shilpa GV; Deshpande G; Thakkar H; Shah H; Ojha HR; Jani H; Gontia J; Mishrikotkar JP; Likhari K; Prajapati K; Porwal K; Koka K; Dharawat KS; Ramamurthy LB; Bhattacharyya M; Saini M; Christy MC; Das M; Hada M; Panchal M; Pandharpurkar M; Ali MO; Porwal M; Gangashetappa N; Mehrotra N; Bijlani N; Gajendragadkar N; Nagarkar NM; Modi P; Rewri P; Sao P; Patil PS; Giri P; Kapadia P; Yadav P; Bhagat P; Parekh R; Dyaberi R; Chauhan RS; Kaur R; Duvesh RK; Murthy R; Dandu RV; Kathiara R; Beri R; Pandit R; Rani RH; Gupta R; Pherwani R; Sapkal R; Mehta R; Tadepalli S; Fatima S; Karmarkar S; Patil SS; Shah S; Shah S; Shah S; Dubey S; Gandhi S; Kanakpur S; Mohan S; Bhomaj S; Kerkar S; Jariwala S; Sahu S; Tara S; Maru SK; Jhavar S; Sharma S; Gupta S; Kumari S; Das S; Menon S; Burkule S; Nisar SP; Kaliaperumal S; Rao S; Pakrasi S; Rathod S; Biradar SG; Kumar S; Dutt S; Bansal S; Ravani SA; Lohiya S; Ali Rizvi SW; Gokhale T; Lahane TP; Vukkadala T; Grover T; Bhesaniya T; Chawla U; Singh U; Une VL; Nandedkar V; Subramaniam V; Eswaran V; Chaudhry VN; Rangarajan V; Dehane V; Sahasrabudhe VM; Sowjanya Y; Tupkary Y; Phadke Y; Indian J Ophthalmol; 2021 Jul; 69(7):1670-1692. PubMed ID: 34156034 [TBL] [Abstract][Full Text] [Related]
15. Glycemic status affects the severity of coronavirus disease 2019 in patients with diabetes mellitus: an observational study of CT radiological manifestations using an artificial intelligence algorithm. Lu X; Cui Z; Pan F; Li L; Li L; Liang B; Yang L; Zheng C Acta Diabetol; 2021 May; 58(5):575-586. PubMed ID: 33420614 [TBL] [Abstract][Full Text] [Related]
16. Mass urine sugar testing to tackle post-COVID mucormycosis epidemic in India-MUSTARD concept. Garg P; Mittal S Diabetes Metab Syndr; 2021; 15(4):102177. PubMed ID: 34198108 [TBL] [Abstract][Full Text] [Related]
17. Risk factors for COVID-19 associated mucormycosis in India: A case control study. Patel AK; Bakshi H; Shah K; Patel S; Patel T; Patel K; Patel KK Med Mycol; 2022 Jul; 60(7):. PubMed ID: 35709394 [TBL] [Abstract][Full Text] [Related]
18. Impact of the COVID-19 Pandemic on Glycemic Control and Blood Pressure Control in Patients with Diabetes in Japan. Endo K; Miki T; Itoh T; Kubo H; Ito R; Ohno K; Hotta H; Kato N; Matsumoto T; Kitamura A; Tamayama M; Wataya T; Yamaya A; Ishikawa R; Ooiwa H Intern Med; 2022; 61(1):37-48. PubMed ID: 34980759 [TBL] [Abstract][Full Text] [Related]
20. A Novel Study of Correlation of Lipid Parameters with Clinical Profile, Staging and Onset of Rhino Orbito Cerebral Mucormycosis Covid 19 Pandemic. V V; St K J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443508 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]